Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001334841 | SCV001527809 | uncertain significance | Intellectual disability, autosomal recessive 43 | 2018-02-13 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004035784 | SCV004979476 | uncertain significance | not specified | 2022-12-06 | criteria provided, single submitter | clinical testing | The c.641A>G (p.K214R) alteration is located in exon 9 (coding exon 9) of the KIAA1033 gene. This alteration results from a A to G substitution at nucleotide position 641, causing the lysine (K) at amino acid position 214 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |